BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35409195)

  • 1. Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives.
    Loda A; Turati M; Semeraro F; Rezzola S; Ronca R
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
    Ronca R; Giacomini A; Rusnati M; Presta M
    Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of fibroblast growth factors in tumor growth.
    Korc M; Friesel RE
    Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF/FGFR signaling in bone formation: progress and perspectives.
    Marie PJ; Miraoui H; Sévère N
    Growth Factors; 2012 Apr; 30(2):117-23. PubMed ID: 22292523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
    Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
    J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
    Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
    Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
    Presta M; Chiodelli P; Giacomini A; Rusnati M; Ronca R
    Pharmacol Ther; 2017 Nov; 179():171-187. PubMed ID: 28564583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
    Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S
    Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B; Ozen M; Ittmann M
    Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics.
    Parish A; Schwaederle M; Daniels G; Piccioni D; Fanta P; Schwab R; Shimabukuro K; Parker BA; Helsten T; Kurzrock R
    Cell Cycle; 2015; 14(13):2121-8. PubMed ID: 25950492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-canonical fibroblast growth factor signalling in angiogenesis.
    Murakami M; Elfenbein A; Simons M
    Cardiovasc Res; 2008 May; 78(2):223-31. PubMed ID: 18056763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
    Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
    Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
    Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
    Flippot R; Kone M; Magné N; Vignot S
    Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptors and their ligands in the adult rat kidney.
    Cancilla B; Davies A; Cauchi JA; Risbridger GP; Bertram JF
    Kidney Int; 2001 Jul; 60(1):147-55. PubMed ID: 11422746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factors in the developing central nervous system.
    Ford-Perriss M; Abud H; Murphy M
    Clin Exp Pharmacol Physiol; 2001 Jul; 28(7):493-503. PubMed ID: 11422214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.